Tag:
Unit Dose Budesonide
Latest Headlines
Latest Headlines
AZ, MAP ink $900M asthma drug deal
AstraZeneca and MAP Pharmaceuticals have signed a development and commercialization deal covering Phase III asthma drug Unit Dose Budesonide (UDB), MAP's nebulized formulation of budesonide. MAP gets
